|
令和4年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査担当
1 腸管出血性大腸菌の発生状況累計グラフ
（1）散発患者発生動向調査
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
0 |
4 |
1 |
1 |
1 |
2 |
| O157VT1,2 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
2 |
4 |
6 |
9 |
4 |
4 |
| その他 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
3 |
3 |
3 |
7 |
1 |
2 |
| 累計 |
1 |
1 |
2 |
2 |
2 |
2 |
2 |
2 |
5 |
5 |
8 |
9 |
14 |
25 |
35 |
52 |
58 |
66 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
2 |
4 |
9 |
3 |
7 |
2 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
| O157VT1,2 |
4 |
10 |
8 |
7 |
5 |
5 |
5 |
5 |
5 |
1 |
2 |
2 |
1 |
1 |
1 |
1 |
1 |
0 |
| その他 |
2 |
2 |
5 |
1 |
2 |
3 |
1 |
1 |
1 |
3 |
0 |
1 |
0 |
1 |
3 |
1 |
1 |
0 |
| 累計 |
74 |
90 |
112 |
123 |
137 |
147 |
155 |
161 |
167 |
172 |
174 |
177 |
178 |
180 |
184 |
186 |
189 |
189 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
0 |
1 |
0 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
3 |
2 |
0 |
| その他 |
0 |
3 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
1 |
1 |
2 |
2 |
| 累計 |
0 |
4 |
4 |
4 |
5 |
6 |
6 |
6 |
6 |
6 |
7 |
8 |
13 |
16 |
17 |
21 |
26 |
28 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
3 |
0 |
1 |
1 |
3 |
1 |
0 |
1 |
0 |
1 |
3 |
0 |
0 |
1 |
1 |
0 |
2 |
0 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
1 |
3 |
1 |
1 |
1 |
2 |
4 |
1 |
2 |
2 |
1 |
1 |
1 |
3 |
0 |
4 |
1 |
0 |
| 累計 |
32 |
35 |
37 |
39 |
44 |
47 |
51 |
53 |
55 |
58 |
62 |
63 |
64 |
68 |
69 |
73 |
76 |
76 |
2 サルモネラの発生状況累計グラフ
（1）散発患者発生動向調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| 累計 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
3 |
4 |
4 |
5 |
6 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
0 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
6 |
6 |
6 |
7 |
8 |
8 |
9 |
13 |
13 |
16 |
17 |
17 |
17 |
17 |
17 |
17 |
17 |
17 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
2 |
0 |
5 |
1 |
0 |
| O7 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
1 |
| O9 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
2 |
0 |
| 累計 |
1 |
1 |
1 |
3 |
3 |
3 |
3 |
3 |
4 |
5 |
5 |
6 |
7 |
10 |
12 |
17 |
20 |
21 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
| O7 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
14 |
6 |
9 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
| 累計 |
23 |
23 |
23 |
24 |
24 |
24 |
25 |
26 |
26 |
28 |
29 |
29 |
43 |
49 |
58 |
60 |
62 |
62 |
|
